Kaken Pharmaceutical Co (TSE:4521) Dividend Payout Ratio: 4.82 (As of Mar. 2026) — 1076% Above Median

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Kaken Pharmaceutical Co Ltd TSE:4521

69 GF Score

Price 円3,900.00

GF Value 円3,775.44

Valuation Fairly Valued

2 Warning Signs

View Full Analysis

What is Kaken Pharmaceutical Co Dividend Payout Ratio?

Kaken Pharmaceutical Co TSE:4521 +1.04% 69 Dividend Payout Ratio is 4.82 as of Mar. 2026, which is 1076% above its 10-year median of 0.41. GuruFocus rates TSE:4521 with a GF Score™ of 69/100 and a GF Value™ of 円3,775.44 (Fairly Valued). The stock has 2 warning signs investors should review. Among 445 Drug Manufacturers companies, Kaken Pharmaceutical Co ranks worse than 98.43% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Kaken Pharmaceutical Co's Dividend Payout Ratio for the months ended in Mar. 2026 was 4.82.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Kaken Pharmaceutical Co Ltd is 3.36, which seems too high.

The historical rank and industry rank for Kaken Pharmaceutical Co's Dividend Payout Ratio or its related term are showing as below:

TSE:4521' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.28 Med: 0.41 Max: 3.36
Current: 3.36

During the past 13 years, the highest Dividend Payout Ratio of Kaken Pharmaceutical Co was 3.36. The lowest was 0.28. And the median was 0.41.

TSE:4521's Dividend Payout Ratio is ranked worse than
98.43% of 445 companies
in the Drug Manufacturers industry
Industry Median: 0.38 vs TSE:4521: 3.36

As of today (2026-07-21), the Dividend Yield % of Kaken Pharmaceutical Co is 4.92%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Kaken Pharmaceutical Co was 5.03%. The lowest was 1.95%. And the median was 3.43%.

Kaken Pharmaceutical Co's Dividends per Share for the months ended in Mar. 2026 was 円95.00.

During the past 12 months, Kaken Pharmaceutical Co's average Dividends Per Share Growth Rate was 26.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 8.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 3.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 1.50% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Kaken Pharmaceutical Co was 20.80% per year. The lowest was 0.00% per year. And the median was 13.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Kaken Pharmaceutical Co (TSE:4521) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Kaken Pharmaceutical Co Dividend Payout Ratio Related Terms

Kaken Pharmaceutical Co Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Kaken Pharmaceutical Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaken Pharmaceutical Co Dividend Payout Ratio Chart

Kaken Pharmaceutical Co Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

Dividend Payout Ratio

Get a 7-Day Free Trial

0.47

0.81

0.69

0.37

3.36

Kaken Pharmaceutical Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Dividend Payout Ratio	Get a 7-Day Free Trial															0.00	0.00	20.29	0.00	4.82

TSE:4521 vs ZTS, UTHR: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kaken Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kaken Pharmaceutical Co Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaken Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Kaken Pharmaceutical Co's Dividend Payout Ratio falls into.

Save Embed

69GF Score

Kaken Pharmaceutical Co Ltd TSE:4521

Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Kaken Pharmaceutical Co Dividend Payout Ratio Calculation

Kaken Pharmaceutical Co's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Mar. 2026 )	/	Earnings per Share (Diluted) (A: Mar. 2026 )
	=	190	/	56.57
	=	3.36

Kaken Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2026 )	/	Earnings per Share (Diluted) (Q: Mar. 2026 )
	=	95	/	19.7
	=	4.82

Frequently Asked Questions Learn more about Dividend Payout Ratio →

What does a Dividend Payout Ratio of 4.82 mean?

Kaken Pharmaceutical Co (TSE:4521) has a Dividend Payout Ratio of 4.82 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Kaken Pharmaceutical Co and its competitors. This is 1076% above median its historical median of 0.41. Over the past decade, Kaken Pharmaceutical Co's Dividend Payout Ratio has ranged from 0.28 to 3.36. According to the industry distribution chart, Kaken Pharmaceutical Co ranks #438 out of 445 companies in the Drug Manufacturers industry, placing it in the top 98.4%.

Is Kaken Pharmaceutical Co's Dividend Payout Ratio too high?

Kaken Pharmaceutical Co's current Dividend Payout Ratio of 4.82 is 1076% above median its 10-year median of 0.41. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 3.36. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Kaken Pharmaceutical Co's value of 4.82 is 1168.4% above this industry median. Based on the distribution chart, Kaken Pharmaceutical Co ranks #438 out of 445 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Kaken Pharmaceutical Co has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Kaken Pharmaceutical Co's Dividend Payout Ratio compare to ZTS and UTHR?

According to the Drug Manufacturers industry distribution chart, Kaken Pharmaceutical Co ranks #438 out of 445 companies for Dividend Payout Ratio. This places Kaken Pharmaceutical Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Kaken Pharmaceutical Co's value of 4.82 is 1168.4% above this benchmark. Historically, Kaken Pharmaceutical Co's own Dividend Payout Ratio has ranged from 0.28 to 3.36 over the past decade. While the company's 10-year median is 0.41 vs. the industry median of 0.38, Kaken Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividend Payout Ratio for a Drug Manufacturers company?

The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kaken Pharmaceutical Co's current Dividend Payout Ratio of 4.82 is 1168.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividend Payout Ratio mean?

A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Kaken Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kaken Pharmaceutical Co's current Dividend Payout Ratio is 4.82, which is 1076% above median its own 10-year median of 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Kaken Pharmaceutical Co stock overvalued right now?

Based on GuruFocus' analysis, Kaken Pharmaceutical Co (TSE:4521) is currently considered Fairly Valued. The stock's GF Value™ is 円3,775.44, compared to a current price of 円3,900.00 — trading 3.3% above its estimated fair value. The current Dividend Payout Ratio is 4.82, which is 1076% above median its 10-year median of 0.41 and 1168.4% above the Drug Manufacturers industry median of 0.38. Kaken Pharmaceutical Co's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividend Payout Ratio calculated?

Dividend Payout Ratio is calculated from a company's financial statements. For Kaken Pharmaceutical Co (TSE:4521), the current Dividend Payout Ratio is 4.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kaken Pharmaceutical Co (TSE:4521) Overvalued in 2026?

Based on GuruFocus' analysis, Kaken Pharmaceutical Co stock appears to be overvalued. The current stock price of 円3,900.00 is trading 3.3% above its estimated GF Value™ of 円3,775.44. GuruFocus considers Kaken Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4521:

Dividend Payout Ratio: 4.82 (1076% above median its 10-year median of 0.41)
GF Value™: 円3,775.44 vs. price of 円3,900.00 (3.3% above fair value)
GF Score™: 69/100 with 2 warning signs
Industry Position: 1168.4% above the Drug Manufacturers median (#438 of 445)

No single metric tells the full story. See the TSE:4521 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kaken Pharmaceutical Co Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies TSE:4547 TSE:4534 TSE:4553 TSE:4887 TSE:4559 TSE:4569 TSE:4886 TSE:4554 TSE:4577 TSE:4595 XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Address 28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650

Website http://www.kaken.co.jp

Kaken Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

69GF Score

Get the complete analysis for TSE:4521

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,900.00

Price

円3,775.44

GF Value

View TSE:4521 Analysis

See Dividend Payout Ratio data for all stocks →